| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.882 | 0.003 | 0.882 | Caspase 3 stimulant | 0.864 0.003 CHEMBL3527427 0.864 0.003 CHEMBL3527536 0.848 0.003 CHEMBL1688937 | ||
| 0.805 | 0.004 | 0.805 | 5 Hydroxytryptamine release stimulant | 0.79 0.004 CHEMBL3527427 0.79 0.004 CHEMBL3527536 0.714 0.006 CHEMBL1688937 | ||
| 0.784 | 0.019 | 0.785 | Apoptosis agonist | 0.785 0.018 CHEMBL3527427 0.785 0.018 CHEMBL3527536 0.773 0.02 CHEMBL1688937 | CHEMBL3527536 | |
| 0.775 | 0.015 | 0.829 | Caspase 9 stimulant | 0.829 0.008 CHEMBL3527427 0.829 0.008 CHEMBL3527536 0.671 0.027 CHEMBL1688937 | CHEMBL3527536 | |
| 0.72 | 0.005 | 0.72 | Antimitotic | 0.682 0.005 CHEMBL3527427 0.682 0.005 CHEMBL3527536 0.67 0.005 CHEMBL1688937 | ||
| 0.617 | 0.004 | 0.617 | Topoisomerase II inhibitor | 0.605 0.005 CHEMBL3527427 0.605 0.005 CHEMBL3527536 0.371 0.012 CHEMBL1688937 | ||
| 0.615 | 0.022 | 0.79 | 15-Lipoxygenase inhibitor | 0.79 0.007 CHEMBL3527427 0.79 0.007 CHEMBL3527536 0.64 0.019 CHEMBL1688937 | CHEMBL3527536 | |
| 0.633 | 0.045 | 0.825 | Antiinflammatory | 0.663 0.038 CHEMBL3527427 0.663 0.038 CHEMBL3527536 0.825 0.012 CHEMBL1688937 | CHEMBL1688937 | |
| 0.588 | 0.01 | 0.684 | Nitric oxide antagonist | 0.587 0.01 CHEMBL3527427 0.587 0.01 CHEMBL3527536 0.684 0.006 CHEMBL1688937 | CHEMBL1688937 | |
| 0.588 | 0.012 | 0.774 | Antioxidant | 0.672 0.007 CHEMBL3527427 0.672 0.007 CHEMBL3527536 0.774 0.005 CHEMBL1688937 | CHEMBL1688937 | |
| 0.554 | 0.008 | 0.562 | Vasodilator | 0.538 0.009 CHEMBL3527427 0.538 0.009 CHEMBL3527536 0.562 0.008 CHEMBL1688937 | CHEMBL1688937 | |
| 0.578 | 0.034 | 0.696 | Transcription factor NF kappa B inhibitor | 0.696 0.021 CHEMBL3527427 0.696 0.021 CHEMBL3527536 0.658 0.025 CHEMBL1688937 | CHEMBL3527536 | |
| 0.536 | 0.006 | 0.536 | Hepatoprotectant | 0.509 0.007 CHEMBL3527427 0.509 0.007 CHEMBL3527536 0.44 0.01 CHEMBL1688937 | ||
| 0.526 | 0.005 | 0.575 | Cyclic AMP phosphodiesterase inhibitor | 0.575 0.004 CHEMBL3527427 0.575 0.004 CHEMBL3527536 0.538 0.005 CHEMBL1688937 | CHEMBL3527536 | |
| 0.492 | 0.004 | 0.614 | Neurotrophic factor enhancer | 0.614 0.003 CHEMBL3527427 0.614 0.003 CHEMBL3527536 0.398 0.006 CHEMBL1688937 | CHEMBL3527536 | |
| 0.492 | 0.004 | 0.492 | Topoisomerase I inhibitor | 0.477 0.004 CHEMBL3527427 0.477 0.004 CHEMBL3527536 0.297 0.011 CHEMBL1688937 | ||
| 0.505 | 0.027 | 0.575 | Histamine release inhibitor | 0.575 0.013 CHEMBL3527427 0.575 0.013 CHEMBL3527536 0.511 0.025 CHEMBL1688937 | CHEMBL3527536 | |
| 0.45 | 0.016 | 0.45 | Psychostimulant | 0.417 0.02 CHEMBL3527427 0.417 0.02 CHEMBL3527536 0.344 0.033 CHEMBL1688937 | ||
| 0.398 | 0.004 | 0.531 | Histone deacetylase SIRT1 stimulant | 0.326 0.004 CHEMBL3527427 0.326 0.004 CHEMBL3527536 0.531 0.003 CHEMBL1688937 | CHEMBL1688937 | |
| 0.398 | 0.004 | 0.531 | Histone deacetylase stimulant | 0.326 0.004 CHEMBL3527427 0.326 0.004 CHEMBL3527536 0.531 0.003 CHEMBL1688937 | CHEMBL1688937 | |
| 0.392 | 0.004 | 0.632 | Estrogen agonist | 0.444 0.004 CHEMBL3527427 0.444 0.004 CHEMBL3527536 0.632 0.003 CHEMBL1688937 | CHEMBL1688937 | |
| 0.414 | 0.031 | 0.428 | Vasodilator, coronary | 0.428 0.028 CHEMBL3527427 0.428 0.028 CHEMBL3527536 0.366 0.048 CHEMBL1688937 | CHEMBL3527536 | |
| 0.409 | 0.027 | 0.45 | DNA damaging | 0.45 0.019 CHEMBL3527427 0.45 0.019 CHEMBL3527536 0.32 0.05 CHEMBL1688937 | CHEMBL3527536 | |
| 0.403 | 0.028 | 0.652 | Free radical scavenger | 0.561 0.011 CHEMBL3527427 0.561 0.011 CHEMBL3527536 0.652 0.006 CHEMBL1688937 | CHEMBL1688937 | |
| 0.405 | 0.037 | 0.555 | Apoptosis antagonist | 0.442 0.029 CHEMBL3527427 0.442 0.029 CHEMBL3527536 0.555 0.014 CHEMBL1688937 | CHEMBL1688937 | |
| 0.378 | 0.013 | 0.45 | Tubulin antagonist | 0.45 0.009 CHEMBL3527427 0.45 0.009 CHEMBL3527536 0.249 0.025 CHEMBL1688937 | CHEMBL3527536 | |
| 0.375 | 0.014 | 0.533 | Melanin inhibitor | 0.533 0.005 CHEMBL3527427 0.533 0.005 CHEMBL3527536 0.429 0.01 CHEMBL1688937 | CHEMBL3527536 | |
| 0.454 | 0.094 | 0.609 | Alpha-glucosidase inhibitor | 0.609 0.052 CHEMBL3527427 0.609 0.052 CHEMBL3527536 0.48 0.086 CHEMBL1688937 | CHEMBL3527536 | |
| 0.408 | 0.053 | 0.45 | Vasodilator, peripheral | 0.437 0.044 CHEMBL3527427 0.437 0.044 CHEMBL3527536 0.45 0.04 CHEMBL1688937 | CHEMBL1688937 | |
| 0.359 | 0.005 | 0.359 | CDC-like kinase 1 inhibitor | 0.298 0.01 CHEMBL3527427 0.298 0.01 CHEMBL3527536 | ||
| 0.347 | 0.014 | 0.347 | Cholinergic | 0.281 0.022 CHEMBL3527427 0.281 0.022 CHEMBL3527536 0.265 0.025 CHEMBL1688937 | ||
| 0.339 | 0.006 | 0.359 | Alpha 2 adrenoreceptor antagonist | 0.359 0.006 CHEMBL3527427 0.359 0.006 CHEMBL3527536 0.208 0.017 CHEMBL1688937 | CHEMBL3527536 | |
| 0.336 | 0.006 | 0.505 | Nitric-oxide synthase stimulant | 0.37 0.004 CHEMBL3527427 0.37 0.004 CHEMBL3527536 0.505 0.002 CHEMBL1688937 | CHEMBL1688937 | |
| 0.321 | 0.006 | 0.335 | Topoisomerase II alpha inhibitor | 0.335 0.005 CHEMBL3527427 0.335 0.005 CHEMBL3527536 0.193 0.016 CHEMBL1688937 | CHEMBL3527536 | |
| 0.312 | 0.003 | 0.312 | CDC-like kinase 3 inhibitor | 0.252 0.004 CHEMBL3527427 0.252 0.004 CHEMBL3527536 | ||
| 0.32 | 0.011 | 0.32 | Acetylcholinesterase inhibitor | 0.291 0.014 CHEMBL3527427 0.291 0.014 CHEMBL3527536 0.25 0.02 CHEMBL1688937 | ||
| 0.334 | 0.033 | 0.334 | Sigma receptor agonist | 0.275 0.044 CHEMBL3527427 0.275 0.044 CHEMBL3527536 | ||
| 0.303 | 0.006 | 0.303 | Alpha 2c adrenoreceptor antagonist | 0.287 0.007 CHEMBL3527427 0.287 0.007 CHEMBL3527536 0.213 0.015 CHEMBL1688937 | ||
| 0.391 | 0.096 | 0.653 | Cyclophilin D inhibitor | 0.418 0.081 CHEMBL3527427 0.418 0.081 CHEMBL3527536 0.653 0.019 CHEMBL1688937 | CHEMBL1688937 | |
| 0.316 | 0.048 | 0.406 | Hypoglycemic | 0.366 0.034 CHEMBL3527427 0.366 0.034 CHEMBL3527536 0.406 0.026 CHEMBL1688937 | CHEMBL1688937 | |
| 0.275 | 0.008 | 0.275 | 5 Hydroxytryptamine 3E antagonist | 0.221 0.036 CHEMBL3527427 0.221 0.036 CHEMBL3527536 0.188 0.087 CHEMBL1688937 | ||
| 0.314 | 0.065 | 0.499 | Lipoxygenase inhibitor | 0.499 0.019 CHEMBL3527427 0.499 0.019 CHEMBL3527536 0.463 0.024 CHEMBL1688937 | CHEMBL3527536 | |
| 0.347 | 0.104 | 0.452 | Antibacterial | 0.409 0.073 CHEMBL3527427 0.409 0.073 CHEMBL3527536 0.452 0.056 CHEMBL1688937 | CHEMBL1688937 | |
| 0.307 | 0.068 | 0.365 | Spasmolytic | 0.365 0.048 CHEMBL3527427 0.365 0.048 CHEMBL3527536 0.284 0.077 CHEMBL1688937 | CHEMBL3527536 | |
| 0.24 | 0.004 | 0.523 | Estrogen receptor beta agonist | 0.301 0.004 CHEMBL3527427 0.301 0.004 CHEMBL3527536 0.523 0.003 CHEMBL1688937 | CHEMBL1688937 | |
| 0.257 | 0.026 | 0.411 | Amylase inhibitor | 0.372 0.011 CHEMBL3527427 0.372 0.011 CHEMBL3527536 0.411 0.009 CHEMBL1688937 | CHEMBL1688937 | |
| 0.241 | 0.011 | 0.243 | Microtubule formation inhibitor | 0.243 0.01 CHEMBL3527427 0.243 0.01 CHEMBL3527536 0.242 0.011 CHEMBL1688937 | CHEMBL3527536 | |
| 0.229 | 0.004 | 0.229 | Endothelin receptor antagonist | 0.159 0.004 CHEMBL3527427 0.159 0.004 CHEMBL3527536 | ||
| 0.24 | 0.018 | 0.24 | DNA intercalator | 0.222 0.02 CHEMBL3527427 0.222 0.02 CHEMBL3527536 | ||
| 0.281 | 0.058 | 0.493 | Antiamyloidogenic | 0.415 0.026 CHEMBL3527427 0.415 0.026 CHEMBL3527536 0.493 0.016 CHEMBL1688937 | CHEMBL1688937 | |
| 0.216 | 0.005 | 0.216 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.197 0.007 CHEMBL3527427 0.197 0.007 CHEMBL3527536 | ||
| 0.219 | 0.012 | 0.258 | Alpha 2a adrenoreceptor antagonist | 0.258 0.009 CHEMBL3527427 0.258 0.009 CHEMBL3527536 0.226 0.011 CHEMBL1688937 | CHEMBL3527536 | |
| 0.21 | 0.003 | 0.21 | Endothelin B receptor antagonist | 0.132 0.004 CHEMBL3527427 0.132 0.004 CHEMBL3527536 | ||
| 0.251 | 0.054 | 0.251 | Clk dual-specificity kinase inhibitor | 0.184 0.089 CHEMBL3527427 0.184 0.089 CHEMBL3527536 | ||
| 0.206 | 0.012 | 0.215 | Antineoplastic alkaloid | 0.215 0.01 CHEMBL3527427 0.215 0.01 CHEMBL3527536 0.109 0.042 CHEMBL1688937 | CHEMBL3527536 | |
| 0.197 | 0.003 | 0.197 | Endothelin A receptor antagonist | 0.131 0.004 CHEMBL3527427 0.131 0.004 CHEMBL3527536 | ||
| 0.202 | 0.009 | 0.444 | Estrogen receptor beta antagonist | 0.311 0.005 CHEMBL3527427 0.311 0.005 CHEMBL3527536 0.444 0.004 CHEMBL1688937 | CHEMBL1688937 | |
| 0.216 | 0.035 | 0.216 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.193 0.046 CHEMBL3527427 0.193 0.046 CHEMBL3527536 | ||
| 0.229 | 0.049 | 0.237 | P-glycoprotein inhibitor | 0.237 0.046 CHEMBL3527427 0.237 0.046 CHEMBL3527536 0.225 0.051 CHEMBL1688937 | CHEMBL3527536 | |
| 0.184 | 0.006 | 0.184 | Acetylcholine M3 receptor agonist | 0.148 0.021 CHEMBL3527427 0.148 0.021 CHEMBL3527536 0.169 0.011 CHEMBL1688937 | ||
| 0.179 | 0.006 | 0.179 | Phosphodiesterase 11A inhibitor | 0.129 0.017 CHEMBL3527427 0.129 0.017 CHEMBL3527536 | ||
| 0.179 | 0.006 | 0.179 | Phosphodiesterase XI inhibitor | 0.129 0.017 CHEMBL3527427 0.129 0.017 CHEMBL3527536 | ||
| 0.18 | 0.007 | 0.257 | Alpha tubulin antagonist | 0.257 0.005 CHEMBL3527427 0.257 0.005 CHEMBL3527536 0.083 0.019 CHEMBL1688937 | CHEMBL3527536 | |
| 0.187 | 0.015 | 0.424 | Estrogen antagonist | 0.281 0.007 CHEMBL3527427 0.281 0.007 CHEMBL3527536 0.424 0.004 CHEMBL1688937 | CHEMBL1688937 | |
| 0.192 | 0.019 | 0.279 | Beta amyloid protein antagonist | 0.18 0.024 CHEMBL3527427 0.18 0.024 CHEMBL3527536 0.279 0.007 CHEMBL1688937 | CHEMBL1688937 | |
| 0.258 | 0.093 | 0.36 | Hypoxia-inducible factor 1 alpha inhibitor | 0.36 0.042 CHEMBL3527427 0.36 0.042 CHEMBL3527536 0.276 0.079 CHEMBL1688937 | CHEMBL3527536 | |
| 0.225 | 0.061 | 0.248 | Anesthetic general | 0.228 0.06 CHEMBL3527427 0.228 0.06 CHEMBL3527536 0.248 0.051 CHEMBL1688937 | CHEMBL1688937 | |
| 0.185 | 0.025 | 0.207 | Cyclooxygenase 3 inhibitor | 0.207 0.016 CHEMBL3527427 0.207 0.016 CHEMBL3527536 0.196 0.02 CHEMBL1688937 | CHEMBL3527536 | |
| 0.236 | 0.077 | 0.236 | DNA synthesis inhibitor | 0.223 0.091 CHEMBL3527427 0.223 0.091 CHEMBL3527536 0.214 0.102 CHEMBL1688937 | ||
| 0.159 | 0.005 | 0.169 | Kinesin antagonist | 0.122 0.005 CHEMBL3527427 0.122 0.005 CHEMBL3527536 0.169 0.004 CHEMBL1688937 | CHEMBL1688937 | |
| 0.159 | 0.005 | 0.169 | Kinesin-like protein 1 inhibitor | 0.122 0.005 CHEMBL3527427 0.122 0.005 CHEMBL3527536 0.169 0.004 CHEMBL1688937 | CHEMBL1688937 | |
| 0.243 | 0.088 | 0.475 | 5 Hydroxytryptamine uptake stimulant | 0.272 0.062 CHEMBL3527427 0.272 0.062 CHEMBL3527536 0.475 0.005 CHEMBL1688937 | CHEMBL1688937 | |
| 0.17 | 0.02 | 0.181 | Papain-like protease (SARS coronavirus) inhibitor | 0.181 0.016 CHEMBL3527427 0.181 0.016 CHEMBL3527536 0.146 0.038 CHEMBL1688937 | CHEMBL3527536 | |
| 0.141 | 0.003 | 0.141 | Glutamate (mGluR7) antagonist | 0.126 0.004 CHEMBL3527427 0.126 0.004 CHEMBL3527536 0.096 0.013 CHEMBL1688937 | ||
| 0.158 | 0.02 | 0.158 | Calcium antagonist | 0.085 0.06 CHEMBL3527427 0.085 0.06 CHEMBL3527536 | ||
| 0.142 | 0.005 | 0.206 | Topoisomerase II beta inhibitor | 0.206 0.004 CHEMBL3527427 0.206 0.004 CHEMBL3527536 0.138 0.005 CHEMBL1688937 | CHEMBL3527536 | |
| 0.165 | 0.031 | 0.165 | Pregnane X receptor agonist | 0.16 0.038 CHEMBL3527427 0.16 0.038 CHEMBL3527536 0.16 0.038 CHEMBL1688937 | ||
| 0.168 | 0.034 | 0.23 | Antibacterial (Helicobacter pylori) | 0.159 0.039 CHEMBL3527427 0.159 0.039 CHEMBL3527536 0.23 0.015 CHEMBL1688937 | CHEMBL1688937 | |
| 0.298 | 0.167 | 0.351 | 5 Hydroxytryptamine release inhibitor | 0.273 0.197 CHEMBL3527427 0.273 0.197 CHEMBL3527536 0.351 0.115 CHEMBL1688937 | CHEMBL1688937 | |
| 0.146 | 0.016 | 0.146 | Dopamine D3 antagonist | 0.122 0.02 CHEMBL3527427 0.122 0.02 CHEMBL3527536 0.057 0.048 CHEMBL1688937 | ||
| 0.142 | 0.012 | 0.152 | Phosphodiesterase 6D inhibitor | 0.152 0.009 CHEMBL3527427 0.152 0.009 CHEMBL3527536 0.102 0.048 CHEMBL1688937 | CHEMBL3527536 | |
| 0.183 | 0.054 | 0.189 | ATPase inhibitor | 0.189 0.047 CHEMBL3527427 0.189 0.047 CHEMBL3527536 0.139 0.121 CHEMBL1688937 | CHEMBL3527536 | |
| 0.166 | 0.038 | 0.17 | MAP kinase kinase 4 inhibitor | 0.17 0.032 CHEMBL3527427 0.17 0.032 CHEMBL3527536 0.156 0.052 CHEMBL1688937 | CHEMBL3527536 | |
| 0.15 | 0.024 | 0.35 | Beta glucuronidase inhibitor | 0.235 0.009 CHEMBL3527427 0.235 0.009 CHEMBL3527536 0.35 0.005 CHEMBL1688937 | CHEMBL1688937 | |
| 0.166 | 0.04 | 0.203 | Adenylate cyclase stimulant | 0.192 0.018 CHEMBL3527427 0.192 0.018 CHEMBL3527536 0.203 0.012 CHEMBL1688937 | CHEMBL1688937 | |
| 0.177 | 0.052 | 0.443 | NOS3 expression enhancer | 0.269 0.023 CHEMBL3527427 0.269 0.023 CHEMBL3527536 0.443 0.006 CHEMBL1688937 | CHEMBL1688937 | |
| 0.129 | 0.006 | 0.31 | Estrogen receptor alpha agonist | 0.2 0.004 CHEMBL3527427 0.2 0.004 CHEMBL3527536 0.31 0.003 CHEMBL1688937 | CHEMBL1688937 | |
| 0.248 | 0.126 | 0.363 | Cholesterol antagonist | 0.299 0.092 CHEMBL3527427 0.299 0.092 CHEMBL3527536 0.363 0.059 CHEMBL1688937 | CHEMBL1688937 | |
| 0.195 | 0.078 | 0.223 | Insulin sensitizer | 0.219 0.055 CHEMBL3527427 0.219 0.055 CHEMBL3527536 0.223 0.052 CHEMBL1688937 | CHEMBL1688937 | |
| 0.142 | 0.026 | 0.197 | DOPA decarboxylase inhibitor | 0.197 0.007 CHEMBL3527427 0.197 0.007 CHEMBL3527536 0.153 0.02 CHEMBL1688937 | CHEMBL3527536 | |
| 0.126 | 0.015 | 0.126 | mTOR complex 2 inhibitor | 0.115 0.02 CHEMBL3527427 0.115 0.02 CHEMBL3527536 0.092 0.043 CHEMBL1688937 | ||
| 0.152 | 0.042 | 0.152 | Acetylcholine muscarinic antagonist | 0.136 0.053 CHEMBL3527427 0.136 0.053 CHEMBL3527536 0.111 0.077 CHEMBL1688937 | ||
| 0.13 | 0.021 | 0.13 | Inducible nitric-oxide synthase inhibitor | 0.101 0.036 CHEMBL3527427 0.101 0.036 CHEMBL3527536 | ||
| 0.154 | 0.045 | 0.174 | Alkylator | 0.169 0.037 CHEMBL3527427 0.169 0.037 CHEMBL3527536 0.174 0.035 CHEMBL1688937 | CHEMBL1688937 | |
| 0.15 | 0.044 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.145 0.056 CHEMBL3527427 0.145 0.056 CHEMBL3527536 0.178 0.008 CHEMBL1688937 | CHEMBL1688937 | |
| 0.145 | 0.04 | 0.334 | 5-Lipoxygenase inhibitor | 0.252 0.015 CHEMBL3527427 0.252 0.015 CHEMBL3527536 0.334 0.008 CHEMBL1688937 | CHEMBL1688937 | |
| 0.11 | 0.005 | 0.11 | Alpha-mannosidase inhibitor | 0.095 0.007 CHEMBL3527427 0.095 0.007 CHEMBL3527536 0.085 0.009 CHEMBL1688937 | ||
| 0.122 | 0.018 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.128 0.015 CHEMBL3527427 0.128 0.015 CHEMBL3527536 0.084 0.069 CHEMBL1688937 | CHEMBL3527536 | |
| 0.127 | 0.023 | 0.249 | Macrophage migration inhibitory factor inhibitor | 0.249 0.005 CHEMBL3527427 0.249 0.005 CHEMBL3527536 0.196 0.008 CHEMBL1688937 | CHEMBL3527536 | |
| 0.144 | 0.042 | 0.144 | Alpha 2b adrenoreceptor antagonist | 0.136 0.046 CHEMBL3527427 0.136 0.046 CHEMBL3527536 0.096 0.079 CHEMBL1688937 | ||
| 0.12 | 0.019 | 0.12 | Phosphodiesterase V inhibitor | 0.089 0.033 CHEMBL3527427 0.089 0.033 CHEMBL3527536 | ||
| 0.176 | 0.081 | 0.176 | CDC-like kinase 4 inhibitor | |||
| 0.221 | 0.129 | 0.361 | 12-Lipoxygenase inhibitor | 0.361 0.053 CHEMBL3527427 0.361 0.053 CHEMBL3527536 0.248 0.11 CHEMBL1688937 | CHEMBL3527536 | |
| 0.111 | 0.019 | 0.181 | Beta tubulin antagonist | 0.181 0.009 CHEMBL3527427 0.181 0.009 CHEMBL3527536 0.089 0.026 CHEMBL1688937 | CHEMBL3527536 | |
| 0.134 | 0.042 | 0.134 | Alpha adrenoreceptor antagonist | 0.124 0.046 CHEMBL3527427 0.124 0.046 CHEMBL3527536 0.084 0.068 CHEMBL1688937 | ||
| 0.117 | 0.028 | 0.125 | Ornithine decarboxylase inhibitor | 0.123 0.023 CHEMBL3527427 0.123 0.023 CHEMBL3527536 0.125 0.022 CHEMBL1688937 | CHEMBL1688937 | |
| 0.109 | 0.022 | 0.231 | Dopamine D1 antagonist | 0.231 0.009 CHEMBL3527427 0.231 0.009 CHEMBL3527536 0.167 0.013 CHEMBL1688937 | CHEMBL3527536 | |
| 0.161 | 0.076 | 0.232 | Arachidonic acid antagonist | 0.187 0.046 CHEMBL3527427 0.187 0.046 CHEMBL3527536 0.232 0.011 CHEMBL1688937 | CHEMBL1688937 | |
| 0.092 | 0.007 | 0.092 | Mannosidase inhibitor | 0.079 0.009 CHEMBL3527427 0.079 0.009 CHEMBL3527536 0.073 0.01 CHEMBL1688937 | ||
| 0.109 | 0.026 | 0.175 | Keratolytic | 0.175 0.011 CHEMBL3527427 0.175 0.011 CHEMBL3527536 0.151 0.014 CHEMBL1688937 | CHEMBL3527536 | |
| 0.108 | 0.025 | 0.108 | Alpha adrenoreceptor agonist | 0.107 0.025 CHEMBL3527427 0.107 0.025 CHEMBL3527536 0.101 0.027 CHEMBL1688937 | ||
| 0.177 | 0.097 | 0.24 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.223 0.056 CHEMBL3527427 0.223 0.056 CHEMBL3527536 0.24 0.047 CHEMBL1688937 | CHEMBL1688937 | |
| 0.13 | 0.051 | 0.475 | Cystathionine beta-synthase inhibitor | 0.236 0.017 CHEMBL3527427 0.236 0.017 CHEMBL3527536 0.475 0.004 CHEMBL1688937 | CHEMBL1688937 | |
| 0.184 | 0.106 | 0.29 | Hypolipemic | 0.184 0.106 CHEMBL3527427 0.184 0.106 CHEMBL3527536 0.29 0.052 CHEMBL1688937 | CHEMBL1688937 | |
| 0.105 | 0.028 | 0.128 | Glycine receptor antagonist | 0.089 0.044 CHEMBL3527427 0.089 0.044 CHEMBL3527536 0.128 0.014 CHEMBL1688937 | CHEMBL1688937 | |
| 0.134 | 0.06 | 0.134 | Acetylcholine antagonist | 0.112 0.077 CHEMBL3527427 0.112 0.077 CHEMBL3527536 0.098 0.095 CHEMBL1688937 | ||
| 0.135 | 0.061 | 0.135 | Cholinergic antagonist | 0.114 0.079 CHEMBL3527427 0.114 0.079 CHEMBL3527536 0.1 0.096 CHEMBL1688937 | ||
| 0.078 | 0.004 | 0.081 | Sodium/glucose cotransporter 2 inhibitor | 0.081 0.004 CHEMBL3527427 0.081 0.004 CHEMBL3527536 0.078 0.004 CHEMBL1688937 | CHEMBL3527536 | |
| 0.093 | 0.021 | 0.093 | Adrenaline uptake inhibitor | 0.06 0.044 CHEMBL3527427 0.06 0.044 CHEMBL3527536 0.077 0.029 CHEMBL1688937 | ||
| 0.076 | 0.005 | 0.089 | Melatonin 1 agonist | 0.059 0.007 CHEMBL3527427 0.059 0.007 CHEMBL3527536 0.089 0.004 CHEMBL1688937 | CHEMBL1688937 | |
| 0.128 | 0.058 | 0.128 | DNA repair enzyme inhibitor | 0.124 0.064 CHEMBL3527427 0.124 0.064 CHEMBL3527536 0.109 0.099 CHEMBL1688937 | ||
| 0.122 | 0.052 | 0.183 | Mucolytic | 0.152 0.031 CHEMBL3527427 0.152 0.031 CHEMBL3527536 0.183 0.018 CHEMBL1688937 | CHEMBL1688937 | |
| 0.078 | 0.009 | 0.078 | Adenylate cyclase 1 inhibitor | 0.057 0.02 CHEMBL3527427 0.057 0.02 CHEMBL3527536 0.046 0.031 CHEMBL1688937 | ||
| 0.096 | 0.028 | 0.096 | Phosphodiesterase 5A inhibitor | 0.074 0.046 CHEMBL3527427 0.074 0.046 CHEMBL3527536 | ||
| 0.097 | 0.033 | 0.184 | Histidine decarboxylase inhibitor | 0.177 0.016 CHEMBL3527427 0.177 0.016 CHEMBL3527536 0.184 0.015 CHEMBL1688937 | CHEMBL1688937 | |
| 0.151 | 0.088 | 0.274 | Mcl-1 antagonist | 0.239 0.04 CHEMBL3527427 0.239 0.04 CHEMBL3527536 0.274 0.028 CHEMBL1688937 | CHEMBL1688937 | |
| 0.088 | 0.025 | 0.088 | Acetylcholine M2 receptor antagonist | 0.06 0.045 CHEMBL3527427 0.06 0.045 CHEMBL3527536 | ||
| 0.09 | 0.028 | 0.09 | Phosphodiesterase VI inhibitor | 0.089 0.029 CHEMBL3527427 0.089 0.029 CHEMBL3527536 | ||
| 0.093 | 0.034 | 0.118 | Glutamate decarboxylase inhibitor | 0.118 0.021 CHEMBL3527427 0.118 0.021 CHEMBL3527536 0.089 0.037 CHEMBL1688937 | CHEMBL3527536 | |
| 0.082 | 0.023 | 0.082 | Alpha 1 adrenoreceptor agonist | 0.069 0.028 CHEMBL3527427 0.069 0.028 CHEMBL3527536 0.06 0.036 CHEMBL1688937 | ||
| 0.184 | 0.125 | 0.249 | RNA-directed DNA polymerase inhibitor | 0.202 0.097 CHEMBL3527427 0.202 0.097 CHEMBL3527536 0.249 0.05 CHEMBL1688937 | CHEMBL1688937 | |
| 0.117 | 0.06 | 0.117 | Sphingosine 1-phosphate receptor 2 agonist | 0.107 0.081 CHEMBL3527427 0.107 0.081 CHEMBL3527536 | ||
| 0.157 | 0.1 | 0.282 | Succinate dehydrogenase inhibitor | 0.184 0.063 CHEMBL3527427 0.184 0.063 CHEMBL3527536 0.282 0.014 CHEMBL1688937 | CHEMBL1688937 | |
| 0.091 | 0.034 | 0.241 | Estrogen receptor alpha antagonist | 0.15 0.011 CHEMBL3527427 0.15 0.011 CHEMBL3527536 0.241 0.006 CHEMBL1688937 | CHEMBL1688937 | |
| 0.073 | 0.017 | 0.073 | Acetylcholine M2 receptor agonist | 0.068 0.021 CHEMBL1688937 | ||
| 0.085 | 0.03 | 0.085 | Acetylcholine M5 receptor agonist | 0.063 0.052 CHEMBL1688937 | ||
| 0.07 | 0.018 | 0.079 | Ryanodine receptor antagonist | 0.079 0.009 CHEMBL3527427 0.079 0.009 CHEMBL3527536 0.058 0.042 CHEMBL1688937 | CHEMBL3527536 | |
| 0.09 | 0.041 | 0.1 | Thioredoxin reductase inhibitor | 0.09 0.041 CHEMBL3527427 0.09 0.041 CHEMBL3527536 0.1 0.029 CHEMBL1688937 | CHEMBL1688937 | |
| 0.077 | 0.028 | 0.101 | Neuraminidase inhibitor | 0.089 0.02 CHEMBL3527427 0.089 0.02 CHEMBL3527536 0.101 0.015 CHEMBL1688937 | CHEMBL1688937 | |
| 0.053 | 0.005 | 0.064 | Sodium/glucose cotransporter inhibitor | 0.059 0.004 CHEMBL3527427 0.059 0.004 CHEMBL3527536 0.064 0.004 CHEMBL1688937 | CHEMBL1688937 | |
| 0.089 | 0.041 | 0.089 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.112 | 0.064 | 0.112 | Activin receptor-like kinase 4 inhibitor | |||
| 0.077 | 0.03 | 0.077 | Exportin-1 inhibitor | |||
| 0.082 | 0.036 | 0.163 | Glycine receptor agonist | 0.073 0.049 CHEMBL3527427 0.073 0.049 CHEMBL3527536 0.163 0.005 CHEMBL1688937 | CHEMBL1688937 | |
| 0.164 | 0.119 | 0.223 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.223 0.08 CHEMBL3527427 0.223 0.08 CHEMBL3527536 | CHEMBL3527536 | |
| 0.128 | 0.085 | 0.218 | Protein kinase stimulant | 0.172 0.054 CHEMBL3527427 0.172 0.054 CHEMBL3527536 0.218 0.035 CHEMBL1688937 | CHEMBL1688937 | |
| 0.059 | 0.016 | 0.064 | Microtubule stabilization | 0.055 0.021 CHEMBL3527427 0.055 0.021 CHEMBL3527536 0.064 0.01 CHEMBL1688937 | CHEMBL1688937 | |
| 0.055 | 0.013 | 0.055 | Phosphodiesterase 6C inhibitor | 0.049 0.024 CHEMBL3527427 0.049 0.024 CHEMBL3527536 | ||
| 0.078 | 0.036 | 0.078 | Glucagon-like peptide 1 agonist | 0.063 0.046 CHEMBL3527427 0.063 0.046 CHEMBL3527536 0.06 0.048 CHEMBL1688937 | ||
| 0.086 | 0.045 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.089 0.041 CHEMBL3527427 0.089 0.041 CHEMBL3527536 0.116 0.018 CHEMBL1688937 | CHEMBL1688937 | |
| 0.102 | 0.061 | 0.102 | Butyrylcholinesterase inhibitor | 0.1 0.062 CHEMBL3527427 0.1 0.062 CHEMBL3527536 | ||
| 0.153 | 0.112 | 0.268 | Pyruvate kinase inhibitor | 0.268 0.056 CHEMBL3527427 0.268 0.056 CHEMBL3527536 | CHEMBL3527536 | |
| 0.045 | 0.004 | 0.045 | Imidazoline I1 receptor antagonist | 0.019 0.018 CHEMBL3527427 0.019 0.018 CHEMBL3527536 | ||
| 0.085 | 0.045 | 0.097 | Dopamine antagonist | 0.097 0.04 CHEMBL3527427 0.097 0.04 CHEMBL3527536 | CHEMBL3527536 | |
| 0.053 | 0.014 | 0.073 | Glucocorticoid antagonist | 0.055 0.013 CHEMBL3527427 0.055 0.013 CHEMBL3527536 0.073 0.008 CHEMBL1688937 | CHEMBL1688937 | |
| 0.132 | 0.093 | 0.132 | Acetylcholine M1 receptor antagonist | 0.124 0.102 CHEMBL3527427 0.124 0.102 CHEMBL3527536 | ||
| 0.07 | 0.032 | 0.07 | Alpha 2 adrenoreceptor agonist | 0.065 0.037 CHEMBL3527427 0.065 0.037 CHEMBL3527536 | ||
| 0.132 | 0.094 | 0.184 | Heat shock protein 90 antagonist | 0.184 0.046 CHEMBL3527427 0.184 0.046 CHEMBL3527536 | CHEMBL3527536 | |
| 0.058 | 0.02 | 0.062 | Factor III inhibitor | 0.062 0.016 CHEMBL3527427 0.062 0.016 CHEMBL3527536 | CHEMBL3527536 | |
| 0.26 | 0.222 | 0.26 | MAP kinase 1 inhibitor | 0.254 0.228 CHEMBL3527427 0.254 0.228 CHEMBL3527536 | ||
| 0.158 | 0.121 | 0.159 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.159 0.12 CHEMBL3527427 0.159 0.12 CHEMBL3527536 | CHEMBL3527536 | |
| 0.072 | 0.035 | 0.094 | Glutamate (mGluR6) antagonist | 0.094 0.013 CHEMBL1688937 | CHEMBL1688937 | |
| 0.08 | 0.043 | 0.091 | GABA B receptor agonist | 0.091 0.025 CHEMBL3527427 0.091 0.025 CHEMBL3527536 0.077 0.049 CHEMBL1688937 | CHEMBL3527536 | |
| 0.09 | 0.053 | 0.09 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.053 | 0.017 | 0.099 | Dopamine D3 agonist | 0.052 0.018 CHEMBL3527427 0.052 0.018 CHEMBL3527536 0.099 0.007 CHEMBL1688937 | CHEMBL1688937 | |
| 0.102 | 0.067 | 0.16 | AMP-activated protein kinase stimulant | 0.132 0.04 CHEMBL3527427 0.132 0.04 CHEMBL3527536 0.16 0.022 CHEMBL1688937 | CHEMBL1688937 | |
| 0.077 | 0.046 | 0.099 | Lipase inhibitor | 0.088 0.035 CHEMBL3527427 0.088 0.035 CHEMBL3527536 0.099 0.028 CHEMBL1688937 | CHEMBL1688937 | |
| 0.041 | 0.01 | 0.041 | Phosphodiesterase 6B inhibitor | 0.03 0.021 CHEMBL3527427 0.03 0.021 CHEMBL3527536 | ||
| 0.111 | 0.08 | 0.164 | MAO inhibitor | 0.164 0.054 CHEMBL3527427 0.164 0.054 CHEMBL3527536 0.101 0.09 CHEMBL1688937 | CHEMBL3527536 | |
| 0.115 | 0.085 | 0.151 | Cyclooxygenase 1 inhibitor | 0.151 0.056 CHEMBL3527427 0.151 0.056 CHEMBL3527536 0.12 0.08 CHEMBL1688937 | CHEMBL3527536 | |
| 0.093 | 0.064 | 0.102 | Alpha 2d adrenoreceptor antagonist | 0.102 0.046 CHEMBL1688937 | CHEMBL1688937 | |
| 0.063 | 0.035 | 0.096 | Heat shock protein 90 beta antagonist | 0.096 0.012 CHEMBL3527427 0.096 0.012 CHEMBL3527536 0.056 0.047 CHEMBL1688937 | CHEMBL3527536 | |
| 0.049 | 0.023 | 0.049 | Glutamate (mGluR group III) antagonist | |||
| 0.112 | 0.086 | 0.214 | Alpha-N-acetylglucosaminidase inhibitor | 0.214 0.03 CHEMBL1688937 | CHEMBL1688937 | |
| 0.04 | 0.015 | 0.057 | Melatonin agonist | 0.035 0.02 CHEMBL3527427 0.035 0.02 CHEMBL3527536 0.057 0.008 CHEMBL1688937 | CHEMBL1688937 | |
| 0.19 | 0.164 | 0.19 | Gastrin inhibitor | |||
| 0.071 | 0.048 | 0.098 | Secretase beta inhibitor | 0.098 0.019 CHEMBL1688937 | CHEMBL1688937 | |
| 0.025 | 0.003 | 0.025 | Imidazoline I2 receptor antagonist | 0.01 0.009 CHEMBL3527427 0.01 0.009 CHEMBL3527536 | ||
| 0.153 | 0.133 | 0.211 | Dyrk kinase inhibitor | 0.211 0.092 CHEMBL3527427 0.211 0.092 CHEMBL3527536 | CHEMBL3527536 | |
| 0.059 | 0.039 | 0.059 | Dopamine uptake inhibitor | 0.05 0.049 CHEMBL1688937 | ||
| 0.029 | 0.009 | 0.029 | Phosphodiesterase 6H inhibitor | 0.023 0.017 CHEMBL3527427 0.023 0.017 CHEMBL3527536 | ||
| 0.029 | 0.009 | 0.029 | Phosphodiesterase 6G inhibitor | 0.023 0.017 CHEMBL3527427 0.023 0.017 CHEMBL3527536 | ||
| 0.095 | 0.075 | 0.18 | Expectorant | 0.131 0.044 CHEMBL3527427 0.131 0.044 CHEMBL3527536 0.18 0.025 CHEMBL1688937 | CHEMBL1688937 | |
| 0.063 | 0.044 | 0.063 | Nitric oxide donor | 0.06 0.048 CHEMBL3527427 0.06 0.048 CHEMBL3527536 0.06 0.049 CHEMBL1688937 | ||
| 0.083 | 0.064 | 0.089 | Transcription factor NF kappa B stimulant | 0.089 0.053 CHEMBL3527427 0.089 0.053 CHEMBL3527536 | CHEMBL3527536 | |
| 0.111 | 0.092 | 0.111 | Phosphodiesterase inhibitor | |||
| 0.119 | 0.101 | 0.134 | Cell wall synthesis inhibitor | 0.127 0.089 CHEMBL3527427 0.127 0.089 CHEMBL3527536 0.134 0.082 CHEMBL1688937 | CHEMBL1688937 | |
| 0.087 | 0.069 | 0.123 | MAO B inhibitor | 0.123 0.049 CHEMBL3527427 0.123 0.049 CHEMBL3527536 | CHEMBL3527536 | |
| 0.043 | 0.025 | 0.043 | Plasmepsin II inhibitor | |||
| 0.077 | 0.059 | 0.142 | Antineoplastic antibiotic | 0.094 0.049 CHEMBL3527427 0.094 0.049 CHEMBL3527536 0.142 0.033 CHEMBL1688937 | CHEMBL1688937 | |
| 0.05 | 0.033 | 0.05 | HCV NS3/NS4A protease inhibitor | 0.046 0.04 CHEMBL1688937 | ||
| 0.131 | 0.114 | 0.147 | Heat shock protein 70 antagonist | 0.142 0.067 CHEMBL3527427 0.142 0.067 CHEMBL3527536 0.147 0.053 CHEMBL1688937 | CHEMBL1688937 | |
| 0.059 | 0.042 | 0.115 | Aromatase inhibitor | 0.073 0.032 CHEMBL3527427 0.073 0.032 CHEMBL3527536 0.115 0.019 CHEMBL1688937 | CHEMBL1688937 | |
| 0.093 | 0.077 | 0.093 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.083 | 0.069 | 0.089 | Antiadrenergic | 0.089 0.063 CHEMBL3527427 0.089 0.063 CHEMBL3527536 0.084 0.068 CHEMBL1688937 | CHEMBL3527536 | |
| 0.146 | 0.134 | 0.146 | Anticonvulsant | |||
| 0.08 | 0.068 | 0.086 | Adrenaline antagonist | 0.086 0.063 CHEMBL3527427 0.086 0.063 CHEMBL3527536 0.081 0.067 CHEMBL1688937 | CHEMBL3527536 | |
| 0.209 | 0.198 | 0.363 | Antiobesity | 0.363 0.081 CHEMBL1688937 | CHEMBL1688937 | |
| 0.06 | 0.05 | 0.068 | Dopamine D2 antagonist | 0.068 0.045 CHEMBL3527427 0.068 0.045 CHEMBL3527536 | CHEMBL3527536 | |
| 0.087 | 0.078 | 0.176 | UDP-glucose 4-epimerase inhibitor | 0.176 0.022 CHEMBL1688937 | CHEMBL1688937 | |
| 0.023 | 0.015 | 0.023 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 CHEMBL3527427 0.022 0.018 CHEMBL3527536 0.023 0.015 CHEMBL1688937 | ||
| 0.202 | 0.195 | 0.369 | Immunosuppressant | 0.246 0.151 CHEMBL3527427 0.246 0.151 CHEMBL3527536 0.369 0.077 CHEMBL1688937 | CHEMBL1688937 | |
| 0.043 | 0.038 | 0.05 | Potassium channel Kv1.3 blocker | 0.05 0.03 CHEMBL1688937 | CHEMBL1688937 | |
| 0.045 | 0.039 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.064 0.016 CHEMBL1688937 | CHEMBL1688937 | |
| 0.022 | 0.017 | 0.037 | Prostaglandin F2 alpha agonist | 0.021 0.018 CHEMBL3527427 0.021 0.018 CHEMBL3527536 0.037 0.006 CHEMBL1688937 | CHEMBL1688937 | |
| 0.12 | 0.116 | 0.12 | Thiol protease inhibitor | |||
| 0.084 | 0.081 | 0.312 | Creatine kinase inhibitor | 0.15 0.024 CHEMBL3527427 0.15 0.024 CHEMBL3527536 0.312 0.004 CHEMBL1688937 | CHEMBL1688937 | |
| 0.066 | 0.063 | 0.066 | Acetylcholine M4 receptor antagonist | |||
| 0.086 | 0.085 | 0.086 | Nitric-oxide synthase inhibitor | |||
| 0.014 | 0.013 | 0.014 | Thromboxane A2 agonist | |||
| 0.134 | 0.133 | 0.134 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.124 | 0.124 | 0.157 | MAP kinase 3 inhibitor | 0.157 0.057 CHEMBL1688937 | CHEMBL1688937 | |
| 0.07 | 0.072 | 0.118 | Carbonic anhydrase VI inhibitor | 0.106 0.036 CHEMBL3527427 0.106 0.036 CHEMBL3527536 0.118 0.03 CHEMBL1688937 | CHEMBL1688937 | |
| 0.078 | 0.08 | 0.151 | NADH dehydrogenase inhibitor | 0.079 0.076 CHEMBL3527427 0.079 0.076 CHEMBL3527536 0.151 0.017 CHEMBL1688937 | CHEMBL1688937 | |
| 0.036 | 0.04 | 0.063 | Guanylate cyclase inhibitor | 0.063 0.009 CHEMBL1688937 | CHEMBL1688937 | |
| 0.084 | 0.089 | 0.14 | Anabolic | 0.093 0.073 CHEMBL3527427 0.093 0.073 CHEMBL3527536 0.14 0.024 CHEMBL1688937 | CHEMBL1688937 | |
| 0.112 | 0.117 | 0.167 | Mannose-6-phosphate isomerase inhibitor | 0.128 0.088 CHEMBL3527427 0.128 0.088 CHEMBL3527536 0.167 0.051 CHEMBL1688937 | CHEMBL1688937 | |
| 0.082 | 0.089 | 0.28 | Monophenol monooxygenase inhibitor | 0.175 0.039 CHEMBL3527427 0.175 0.039 CHEMBL3527536 0.28 0.02 CHEMBL1688937 | CHEMBL1688937 | |
| 0.134 | 0.142 | 0.179 | Phospholipase C inhibitor | 0.155 0.096 CHEMBL3527427 0.155 0.096 CHEMBL3527536 0.179 0.062 CHEMBL1688937 | CHEMBL1688937 | |
| 0.029 | 0.038 | 0.047 | Tubulin agonist | 0.034 0.025 CHEMBL3527427 0.034 0.025 CHEMBL3527536 0.047 0.01 CHEMBL1688937 | CHEMBL1688937 | |
| 0.051 | 0.062 | 0.063 | Leukotriene C antagonist | 0.063 0.023 CHEMBL1688937 | CHEMBL1688937 | |
| 0.084 | 0.096 | 0.164 | Carbonic anhydrase XV inhibitor | 0.102 0.065 CHEMBL3527427 0.102 0.065 CHEMBL3527536 0.164 0.026 CHEMBL1688937 | CHEMBL1688937 | |
| 0.058 | 0.071 | 0.066 | Benzodiazepine agonist | 0.066 0.057 CHEMBL1688937 | CHEMBL1688937 | |
| 0.097 | 0.11 | 0.106 | Cyclooxygenase 2 inhibitor | 0.106 0.097 CHEMBL3527427 0.106 0.097 CHEMBL3527536 | CHEMBL3527536 | |
| 0.01 | 0.024 | 0.03 | NMDA receptor phencyclidine site antagonist | 0.03 0.004 CHEMBL1688937 | CHEMBL1688937 | |
| 0.174 | 0.19 | 0.33 | Tyrosine 3 hydroxylase inhibitor | 0.204 0.128 CHEMBL3527427 0.204 0.128 CHEMBL3527536 0.33 0.021 CHEMBL1688937 | CHEMBL1688937 | |
| 0.051 | 0.068 | 0.126 | Phosphofructokinase-1 inhibitor | 0.126 0.023 CHEMBL1688937 | CHEMBL1688937 | |
| 0.031 | 0.048 | 0.048 | Glutamate (mGluR8) agonist | 0.048 0.013 CHEMBL1688937 | CHEMBL1688937 | |
| 0.03 | 0.047 | 0.109 | Dopamine D5 agonist | 0.057 0.013 CHEMBL3527427 0.057 0.013 CHEMBL3527536 0.109 0.004 CHEMBL1688937 | CHEMBL1688937 | |
| 0.06 | 0.078 | 0.074 | MDM2 inhibitor | 0.074 0.029 CHEMBL1688937 | CHEMBL1688937 | |
| 0.045 | 0.063 | 0.097 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.076 0.027 CHEMBL3527427 0.076 0.027 CHEMBL3527536 0.097 0.018 CHEMBL1688937 | CHEMBL1688937 | |
| 0.119 | 0.137 | 0.256 | Interferon gamma antagonist | 0.144 0.086 CHEMBL3527427 0.144 0.086 CHEMBL3527536 0.256 0.027 CHEMBL1688937 | CHEMBL1688937 | |
| 0.012 | 0.031 | 0.019 | Telomerase stimulant | 0.019 0.009 CHEMBL1688937 | CHEMBL1688937 | |
| 0.122 | 0.142 | 0.153 | Interleukin 6 antagonist | 0.153 0.084 CHEMBL3527427 0.153 0.084 CHEMBL3527536 | CHEMBL3527536 | |
| 0.098 | 0.119 | 0.271 | Lipid peroxidase inhibitor | 0.229 0.032 CHEMBL3527427 0.229 0.032 CHEMBL3527536 0.271 0.023 CHEMBL1688937 | CHEMBL1688937 | |
| 0.045 | 0.067 | 0.101 | Androgen agonist | 0.101 0.014 CHEMBL1688937 | CHEMBL1688937 | |
| 0.044 | 0.068 | 0.068 | Alpha 1L adrenoreceptor antagonist | 0.068 0.014 CHEMBL1688937 | CHEMBL1688937 | |
| 0.072 | 0.098 | 0.131 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.131 0.033 CHEMBL1688937 | CHEMBL1688937 | |
| 0.072 | 0.099 | 0.116 | Urease inhibitor | 0.098 0.069 CHEMBL3527427 0.098 0.069 CHEMBL3527536 0.116 0.049 CHEMBL1688937 | CHEMBL1688937 | |
| 0.023 | 0.051 | 0.033 | Farnesoid X receptor agonist | 0.033 0.032 CHEMBL1688937 | CHEMBL1688937 | |
| 0.015 | 0.042 | 0.055 | Dopamine D1 agonist | 0.034 0.007 CHEMBL3527427 0.034 0.007 CHEMBL3527536 0.055 0.004 CHEMBL1688937 | CHEMBL1688937 | |
| 0.025 | 0.054 | 0.081 | Dopamine D5 antagonist | 0.055 0.022 CHEMBL3527427 0.055 0.022 CHEMBL3527536 0.081 0.012 CHEMBL1688937 | CHEMBL1688937 | |
| 0.04 | 0.07 | 0.051 | Leukotriene B4 antagonist | 0.051 0.043 CHEMBL3527427 0.051 0.043 CHEMBL3527536 | CHEMBL3527536 | |
| 0.019 | 0.05 | 0.087 | Progesterone antagonist | 0.087 0.01 CHEMBL1688937 | CHEMBL1688937 | |
| 0.032 | 0.063 | 0.048 | Kainate receptor agonist | 0.048 0.016 CHEMBL1688937 | CHEMBL1688937 | |
| 0.103 | 0.138 | 0.143 | Vanilloid 1 agonist | 0.121 0.085 CHEMBL3527427 0.121 0.085 CHEMBL3527536 0.143 0.046 CHEMBL1688937 | CHEMBL1688937 | |
| 0.042 | 0.077 | 0.16 | Dopamine agonist | 0.097 0.029 CHEMBL3527427 0.097 0.029 CHEMBL3527536 0.16 0.014 CHEMBL1688937 | CHEMBL1688937 | |
| 0.037 | 0.073 | 0.055 | Aconitate hydratase inhibitor | 0.055 0.032 CHEMBL1688937 | CHEMBL1688937 | |
| 0.117 | 0.154 | 0.17 | Antipruritic | 0.17 0.073 CHEMBL1688937 | CHEMBL1688937 | |
| 0.095 | 0.133 | 0.118 | Cyclooxygenase inhibitor | 0.118 0.101 CHEMBL3527427 0.118 0.101 CHEMBL3527536 0.111 0.11 CHEMBL1688937 | CHEMBL3527536 | |
| 0.005 | 0.042 | 0.013 | Glutamate (mGluR6) agonist | 0.013 0.008 CHEMBL1688937 | CHEMBL1688937 | |
| 0.017 | 0.057 | 0.025 | Vanilloid 2 agonist | 0.025 0.018 CHEMBL1688937 | CHEMBL1688937 | |
| 0.024 | 0.064 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.017 CHEMBL1688937 | CHEMBL1688937 | |
| 0.075 | 0.116 | 0.128 | Adenylate cyclase inhibitor | 0.118 0.069 CHEMBL3527427 0.118 0.069 CHEMBL3527536 0.128 0.061 CHEMBL1688937 | CHEMBL1688937 | |
| 0.112 | 0.155 | 0.16 | Platelet adhesion inhibitor | 0.16 0.096 CHEMBL3527427 0.16 0.096 CHEMBL3527536 0.159 0.097 CHEMBL1688937 | CHEMBL3527536 | |
| 0.072 | 0.116 | 0.198 | Protein-tyrosine phosphatase 1B inhibitor | 0.125 0.06 CHEMBL3527427 0.125 0.06 CHEMBL3527536 0.198 0.03 CHEMBL1688937 | CHEMBL1688937 | |
| 0.066 | 0.11 | 0.199 | Prolactin inhibitor | 0.086 0.072 CHEMBL3527427 0.086 0.072 CHEMBL3527536 0.199 0.009 CHEMBL1688937 | CHEMBL1688937 | |
| 0.078 | 0.124 | 0.113 | Adenylate kinase inhibitor | 0.113 0.05 CHEMBL1688937 | CHEMBL1688937 | |
| 0.077 | 0.124 | 0.155 | GABA C receptor antagonist | 0.155 0.027 CHEMBL1688937 | CHEMBL1688937 | |
| 0.037 | 0.084 | 0.062 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.062 0.033 CHEMBL1688937 | CHEMBL1688937 | |
| 0.064 | 0.118 | 0.107 | Triose-phosphate isomerase inhibitor | 0.107 0.041 CHEMBL1688937 | CHEMBL1688937 | |
| 0.05 | 0.105 | 0.081 | Transcription factor RelA inhibitor | 0.081 0.016 CHEMBL1688937 | CHEMBL1688937 | |
| 0.056 | 0.114 | 0.087 | MAO A inhibitor | 0.087 0.074 CHEMBL3527427 0.087 0.074 CHEMBL3527536 | CHEMBL3527536 | |
| 0.066 | 0.127 | 0.123 | GABA C receptor agonist | 0.123 0.048 CHEMBL1688937 | CHEMBL1688937 | |
| 0.094 | 0.156 | 0.209 | Protein-tyrosine phosphatase inhibitor | 0.156 0.073 CHEMBL3527427 0.156 0.073 CHEMBL3527536 0.209 0.043 CHEMBL1688937 | CHEMBL1688937 | |
| 0.043 | 0.107 | 0.08 | Neuraminidase (influenza) inhibitor | 0.061 0.052 CHEMBL3527427 0.061 0.052 CHEMBL3527536 0.08 0.025 CHEMBL1688937 | CHEMBL1688937 | |
| 0.07 | 0.137 | 0.201 | Cholesterol synthesis inhibitor | 0.095 0.094 CHEMBL3527427 0.095 0.094 CHEMBL3527536 0.201 0.026 CHEMBL1688937 | CHEMBL1688937 | |
| 0.033 | 0.099 | 0.061 | Carbamoyl phosphate synthetase inhibitor | 0.061 0.042 CHEMBL1688937 | CHEMBL1688937 | |
| 0.162 | 0.232 | 0.245 | Antithrombotic | 0.245 0.13 CHEMBL1688937 | CHEMBL1688937 | |
| 0.058 | 0.127 | 0.094 | Glutathione S-transferase inhibitor | 0.094 0.043 CHEMBL1688937 | CHEMBL1688937 | |
| 0.064 | 0.138 | 0.179 | Carbonic anhydrase III inhibitor | 0.097 0.065 CHEMBL3527427 0.097 0.065 CHEMBL3527536 0.179 0.02 CHEMBL1688937 | CHEMBL1688937 | |
| 0.035 | 0.109 | 0.084 | Fatty acid synthase inhibitor | 0.084 0.016 CHEMBL1688937 | CHEMBL1688937 | |
| 0.039 | 0.119 | 0.071 | Amidase inhibitor | 0.071 0.047 CHEMBL1688937 | CHEMBL1688937 | |
| 0.098 | 0.177 | 0.127 | Heat shock protein 90 alpha antagonist | 0.127 0.116 CHEMBL3527427 0.127 0.116 CHEMBL3527536 | CHEMBL3527536 | |
| 0.032 | 0.112 | 0.074 | Squalene epoxidase inhibitor | 0.074 0.012 CHEMBL1688937 | CHEMBL1688937 | |
| 0.114 | 0.195 | 0.211 | Immunostimulant | 0.211 0.113 CHEMBL1688937 | CHEMBL1688937 | |
| 0.109 | 0.191 | 0.617 | Aldehyde oxidase inhibitor | 0.221 0.094 CHEMBL3527427 0.221 0.094 CHEMBL3527536 0.617 0.017 CHEMBL1688937 | CHEMBL1688937 | |
| 0.17 | 0.252 | 0.343 | GABA C receptor rho-3 antagonist | 0.343 0.089 CHEMBL1688937 | CHEMBL1688937 | |
| 0.091 | 0.173 | 0.325 | Amyloid beta aggregation inhibitor | 0.315 0.042 CHEMBL3527427 0.315 0.042 CHEMBL3527536 0.325 0.04 CHEMBL1688937 | CHEMBL1688937 | |
| 0.023 | 0.106 | 0.051 | Thromboxane antagonist | 0.051 0.04 CHEMBL1688937 | CHEMBL1688937 | |
| 0.014 | 0.097 | 0.061 | Cathepsin L2 inhibitor | 0.061 0.017 CHEMBL1688937 | CHEMBL1688937 | |
| 0.01 | 0.094 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.015 CHEMBL1688937 | CHEMBL1688937 | |
| 0.055 | 0.139 | 0.205 | HIV-1 integrase (Overall Integration) inhibitor | 0.205 0.011 CHEMBL1688937 | CHEMBL1688937 | |
| 0.045 | 0.129 | 0.076 | Glutamate dehydrogenase inhibitor | 0.076 0.049 CHEMBL1688937 | CHEMBL1688937 | |
| 0.059 | 0.145 | 0.087 | MAP kinase kinase 7 inhibitor | 0.087 0.03 CHEMBL1688937 | CHEMBL1688937 | |
| 0.063 | 0.153 | 0.107 | Estrogen-related receptor beta agonist | 0.107 0.018 CHEMBL1688937 | CHEMBL1688937 | |
| 0.045 | 0.136 | 0.078 | CDC25A inhibitor | 0.075 0.049 CHEMBL3527427 0.075 0.049 CHEMBL3527536 0.078 0.045 CHEMBL1688937 | CHEMBL1688937 | |
| 0.055 | 0.148 | 0.088 | Aminoacyl-tRNA synthetase inhibitor | 0.088 0.063 CHEMBL1688937 | CHEMBL1688937 | |
| 0.02 | 0.115 | 0.053 | Xanthine dehydrogenase inhibitor | 0.053 0.043 CHEMBL1688937 | CHEMBL1688937 | |
| 0.026 | 0.128 | 0.051 | Cholesterol esterase inhibitor | 0.051 0.029 CHEMBL1688937 | CHEMBL1688937 | |
| 0.006 | 0.111 | 0.043 | Arginase inhibitor | 0.043 0.02 CHEMBL1688937 | CHEMBL1688937 | |
| 0.071 | 0.18 | 0.109 | NADPH oxidase inhibitor | 0.109 0.098 CHEMBL3527427 0.109 0.098 CHEMBL3527536 | CHEMBL3527536 | |
| 0.023 | 0.133 | 0.078 | Alcohol oxidase inhibitor | 0.078 0.025 CHEMBL1688937 | CHEMBL1688937 | |
| 0.165 | 0.275 | 0.318 | Calcium channel activator | 0.318 0.075 CHEMBL1688937 | CHEMBL1688937 | |
| 0.223 | 0.335 | 0.275 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.275 0.249 CHEMBL1688937 | CHEMBL1688937 | |
| 0.034 | 0.146 | 0.065 | Purinergic P2X1 antagonist | 0.065 0.037 CHEMBL1688937 | CHEMBL1688937 | |
| 0.041 | 0.153 | 0.066 | Lipocortins synthesis agonist | 0.066 0.025 CHEMBL1688937 | CHEMBL1688937 | |
| 0.059 | 0.171 | 0.131 | Xanthine oxidase inhibitor | 0.086 0.078 CHEMBL3527427 0.086 0.078 CHEMBL3527536 0.131 0.042 CHEMBL1688937 | CHEMBL1688937 | |
| 0.037 | 0.152 | 0.054 | Kallikrein 1 inhibitor | 0.054 0.043 CHEMBL1688937 | CHEMBL1688937 | |
| 0.029 | 0.148 | 0.112 | HIV-1 integrase (3'-Processing) inhibitor | 0.1 0.026 CHEMBL3527427 0.1 0.026 CHEMBL3527536 0.112 0.022 CHEMBL1688937 | CHEMBL1688937 | |
| 0.057 | 0.177 | 0.112 | Granulocyte macrophage colony stimulating factor agonist | 0.112 0.021 CHEMBL1688937 | CHEMBL1688937 | |
| 0.059 | 0.185 | 0.09 | Vanilloid agonist | 0.09 0.048 CHEMBL3527427 0.09 0.048 CHEMBL3527536 0.088 0.05 CHEMBL1688937 | CHEMBL3527536 | |
| 0.017 | 0.145 | 0.071 | Aldose reductase inhibitor | 0.071 0.027 CHEMBL1688937 | CHEMBL1688937 | |
| 0.012 | 0.14 | 0.051 | Dopamine D2 agonist | 0.051 0.026 CHEMBL1688937 | CHEMBL1688937 | |
| 0.033 | 0.162 | 0.115 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.115 0.031 CHEMBL1688937 | CHEMBL1688937 | |
| 0.087 | 0.218 | 0.124 | Hemostatic | 0.124 0.106 CHEMBL1688937 | CHEMBL1688937 | |
| 0.04 | 0.172 | 0.1 | Adrenaline agonist | 0.1 0.037 CHEMBL1688937 | CHEMBL1688937 | |
| 0.076 | 0.212 | 0.165 | Phospholipase A2 inhibitor | 0.165 0.062 CHEMBL1688937 | CHEMBL1688937 | |
| 0.021 | 0.157 | 0.087 | HIV-1 integrase (Strand Transfer) inhibitor | 0.077 0.032 CHEMBL3527427 0.077 0.032 CHEMBL3527536 0.087 0.028 CHEMBL1688937 | CHEMBL1688937 | |
| 0.064 | 0.201 | 0.108 | Photosensitizer | 0.108 0.073 CHEMBL1688937 | CHEMBL1688937 | |
| 0.012 | 0.159 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.027 CHEMBL1688937 | CHEMBL1688937 | |
| 0.068 | 0.215 | 0.435 | Peroxidase inhibitor | 0.119 0.101 CHEMBL3527427 0.119 0.101 CHEMBL3527536 0.435 0.016 CHEMBL1688937 | CHEMBL1688937 | |
| 0.061 | 0.208 | 0.095 | Glutamate release inhibitor | 0.095 0.052 CHEMBL1688937 | CHEMBL1688937 | |
| 0.056 | 0.205 | 0.078 | Ca(v)3.1 blocker | 0.078 0.066 CHEMBL1688937 | CHEMBL1688937 | |
| 0.023 | 0.176 | 0.079 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.079 0.017 CHEMBL1688937 | CHEMBL1688937 | |
| 0.052 | 0.208 | 0.103 | Proteasome inhibitor | 0.103 0.084 CHEMBL1688937 | CHEMBL1688937 | |
| 0.082 | 0.239 | 0.148 | GABA C receptor rho-2 antagonist | 0.148 0.076 CHEMBL1688937 | CHEMBL1688937 | |
| 0.025 | 0.184 | 0.116 | Phenylalanine 4-hydroxylase inhibitor | 0.116 0.019 CHEMBL1688937 | CHEMBL1688937 | |
| 0.027 | 0.188 | 0.094 | Carbonic anhydrase XIII inhibitor | 0.094 0.041 CHEMBL1688937 | CHEMBL1688937 | |
| 0.094 | 0.26 | 0.204 | Lipocortins synthesis antagonist | 0.204 0.054 CHEMBL1688937 | CHEMBL1688937 | |
| 0.031 | 0.201 | 0.054 | Pregnane X receptor antagonist | 0.054 0.047 CHEMBL1688937 | CHEMBL1688937 | |
| 0.011 | 0.182 | 0.051 | Carbonic anhydrase VB inhibitor | 0.051 0.044 CHEMBL1688937 | CHEMBL1688937 | |
| 0.122 | 0.299 | 0.177 | Peptidyltransferase inhibitor | 0.176 0.135 CHEMBL3527427 0.176 0.135 CHEMBL3527536 0.177 0.134 CHEMBL1688937 | CHEMBL1688937 | |
| 0.084 | 0.262 | 0.151 | Non-steroidal antiinflammatory agent | 0.151 0.113 CHEMBL1688937 | CHEMBL1688937 | |
| 0.046 | 0.226 | 0.116 | Bile acid receptor antagonist | 0.116 0.024 CHEMBL1688937 | CHEMBL1688937 | |
| 0.037 | 0.22 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.034 CHEMBL1688937 | CHEMBL1688937 | |
| 0.112 | 0.295 | 0.184 | Transcription factor STAT3 inhibitor | 0.184 0.158 CHEMBL1688937 | CHEMBL1688937 | |
| 0.06 | 0.244 | 0.127 | Neurotrophic factor | 0.127 0.084 CHEMBL1688937 | CHEMBL1688937 | |
| 0.027 | 0.212 | 0.132 | Androgen antagonist | 0.132 0.028 CHEMBL1688937 | CHEMBL1688937 | |
| 0.052 | 0.24 | 0.098 | D-Ala-D-Ala ligase inhibitor | 0.098 0.032 CHEMBL1688937 | CHEMBL1688937 | |
| 0.14 | 0.329 | 0.33 | Analgesic | 0.33 0.12 CHEMBL1688937 | CHEMBL1688937 | |
| 0.022 | 0.217 | 0.071 | Porphobilinogen synthase inhibitor | 0.071 0.055 CHEMBL1688937 | CHEMBL1688937 | |
| 0.005 | 0.201 | 0.023 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.023 0.015 CHEMBL1688937 | CHEMBL1688937 | |
| 0.021 | 0.245 | 0.035 | Glucose-6-phosphate dehydrogenase inhibitor | 0.035 0.034 CHEMBL1688937 | CHEMBL1688937 | |
| 0.024 | 0.249 | 0.06 | Beta adrenoreceptor antagonist | 0.06 0.055 CHEMBL1688937 | CHEMBL1688937 | |
| 0.036 | 0.272 | 0.083 | Protein kinase C zeta inhibitor | 0.083 0.08 CHEMBL1688937 | CHEMBL1688937 | |
| 0.09 | 0.327 | 0.28 | Superoxide dismutase inhibitor | 0.28 0.059 CHEMBL1688937 | CHEMBL1688937 | |
| 0.056 | 0.295 | 0.125 | MAP3K9 inhibitor | 0.125 0.104 CHEMBL1688937 | CHEMBL1688937 | |
| 0.048 | 0.29 | 0.1 | Electron transport complex I inhibitor | 0.1 0.082 CHEMBL1688937 | CHEMBL1688937 | |
| 0.019 | 0.265 | 0.06 | Sphingosine kinase 2 inhibitor | 0.06 0.031 CHEMBL1688937 | CHEMBL1688937 | |
| 0.051 | 0.3 | 0.111 | TRPA1 agonist | 0.111 0.07 CHEMBL1688937 | CHEMBL1688937 | |
| 0.005 | 0.256 | 0.044 | Estradiol 17 beta-dehydrogenase inhibitor | 0.044 0.028 CHEMBL1688937 | CHEMBL1688937 | |
| 0.047 | 0.3 | 0.169 | Toll-Like receptor 2 antagonist | 0.169 0.04 CHEMBL1688937 | CHEMBL1688937 | |
| 0.019 | 0.273 | 0.045 | Dopamine beta hydroxylase inhibitor | 0.045 0.044 CHEMBL1688937 | CHEMBL1688937 | |
| 0.029 | 0.314 | 0.095 | Bronchodilator | 0.095 0.07 CHEMBL1688937 | CHEMBL1688937 | |
| 0.104 | 0.407 | 0.185 | ErbB-1 antagonist | 0.185 0.108 CHEMBL1688937 | CHEMBL1688937 | |
| 0.042 | 0.348 | 0.121 | Aldehyde dehydrogenase inhibitor | 0.121 0.07 CHEMBL1688937 | CHEMBL1688937 | |
| 0.052 | 0.358 | 0.137 | DNA methyltransferase I inhibitor | 0.137 0.12 CHEMBL1688937 | CHEMBL1688937 | |
| 0.015 | 0.321 | 0.101 | Leukotriene synthesis inhibitor | 0.101 0.025 CHEMBL1688937 | CHEMBL1688937 | |
| 0.062 | 0.39 | 0.141 | CF transmembrane conductance regulator agonist | 0.141 0.094 CHEMBL1688937 | CHEMBL1688937 | |
| 0.019 | 0.379 | 0.099 | HIV-1 integrase inhibitor | 0.067 0.053 CHEMBL3527427 0.067 0.053 CHEMBL3527536 0.099 0.025 CHEMBL1688937 | CHEMBL1688937 | |
| 0.032 | 0.415 | 0.186 | DNA polymerase I inhibitor | 0.186 0.033 CHEMBL1688937 | CHEMBL1688937 | |
| 0.01 | 0.402 | 0.039 | Estrogen-related receptor beta antagonist | 0.039 0.012 CHEMBL1688937 | CHEMBL1688937 | |
| 0.043 | 0.443 | 0.201 | Interleukin agonist | 0.201 0.119 CHEMBL1688937 | CHEMBL1688937 | |
| 0.015 | 0.427 | 0.06 | Glucose-6-phosphate translocase inhibitor | 0.06 0.024 CHEMBL1688937 | CHEMBL1688937 | |
| 0.028 | 0.481 | 0.058 | Heme oxygenase stimulant | 0.058 0.051 CHEMBL1688937 | CHEMBL1688937 | |
| 0.065 | 0.523 | 0.187 | Insulysin inhibitor | 0.187 0.178 CHEMBL1688937 | CHEMBL1688937 | |
| 0.023 | 0.52 | 0.231 | Angiogenesis stimulant | 0.231 0.079 CHEMBL1688937 | CHEMBL1688937 | |
| 0.014 | 0.55 | 0.231 | M18 aspartyl aminopeptidase inhibitor | 0.14 0.057 CHEMBL3527427 0.14 0.057 CHEMBL3527536 0.231 0.025 CHEMBL1688937 | CHEMBL1688937 | |
| 0.024 | 0.565 | 0.163 | Farnesoid X receptor antagonist | 0.163 0.04 CHEMBL1688937 | CHEMBL1688937 | |
| 0.084 | 0.719 | 0.279 | Calcium channel L-type activator | 0.279 0.175 CHEMBL1688937 | CHEMBL1688937 | |
| 0.036 | 0.774 | 0.28 | Sodium/bile acid cotransporter inhibitor | 0.28 0.098 CHEMBL1688937 | CHEMBL1688937 | |
| 0.003 | 0.947 | 0.044 | Catechol O-methyltransferase inhibitor | 0.044 0.011 CHEMBL1688937 | CHEMBL1688937 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |